Factors affecting survival of hospitalized patients with COPD

European Respiratory Journal

Volumn 26, Issue 2, 2005, Pages 234-241

  Gunen, H ^a   Hacievliyagil, S S ^a   Kosar, F ^a   Mutlu, L C ^a   Gulbas, G ^a   Pehlivan, E ^a   Sahin, I ^a   Kizkin, O ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Chronic obstructive pulmonary disease; In hospital; Long term survival; Mortality

Indexed keywords

ALBUMIN; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CARBON DIOXIDE; CARDIAC GLYCOSIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIURETIC AGENT; IPRATROPIUM BROMIDE; OXYGEN; PREDNISOLONE; SALBUTAMOL; THEOPHYLLINE;

ADULT; AGED; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; BACTERIAL INFECTION; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; HOSPITAL CARE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OXYGEN SATURATION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

AGED; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SERUM ALBUMIN; SURVIVAL RATE;

EID: 23144436700     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00024804     Document Type: Article

References (21)

1. Murray CJL, Lopez AD. Evidence based health policy-lessons from the Global Burden of disease Study. Science 1996; 274: 740-743.
2. World Health Report. World Health Organisation, Geneva. 2000. www.who.int/whr/2000/en/statistics.htm. Date accessed: January 2004.
3. Mannino DM. COPD: epidemiology, prevalence, morbidity, and mortality, and disease heterogeneity. Chest 2002; 121: Suppl. 5, 121S-126S.
4. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133: 14-20.
5. Seneff MG, Wagner DP, Wagner RP, et al. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995; 274: 1852-1857.
6. Fuso L, Incalzi RA, Pistelli R, et al. Predicting mortality of patients hospitalised for acutely exacerbated chronic obstructive pulmonary disease. Am J Med 1995; 98: 272-276.
7. Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1856-1861.
8. Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 959-967.
9. Groenewegen KH, Schols AMWJ, Wouters EFM. Mortality and mortality-related factors after hospitalisation for acute exacerbation of COPD. Chest 2003; 124: 459-467.
10. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-244.
11. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
12. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
13. ATS Statement. Standardization of spirometry-1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
14. Battle R, Davitt MA, Cooper SM, et al. Prevalence of pulmonary hypertension in limited and diffuse scleroderma. Chest 1996; 110: 1515-1519.
15. Higham MA, Dawson M, Joshi J, et al. Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD. Eur Respir J 2001; 17: 350-355.
16. Patil SP, Krishnan JA, Lechtzin N, et al. In-hospital mortality following acute exacerbations of COPD. Arch Intern Med 2003; 163: 1180-1186.
17. Garcia-Aymerich J, Farrero E, Felez MA, et al. Risk factors for readmision to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58: 100-105.
18. Schols AMW, Slangen J, Volovics L, Wouters EFM. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1791-1797.
19. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. Respir Care 2002; 47: 1184-1199.
20. Soriano JB, Vestbo J, Pride NB, et al. Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 2002; 20: 819-825.
21. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012.